It is a hybrid filler of roughly 5% calcium hydroxylapatite (CaHA) microspheres suspended in about 95% cross-linked hyaluronic acid gel, supplied in a 1.2 mL pre-filled syringe. CaHA microspheres are made of the same calcium-phosphate minerals found in bone.

Calcium hydroxylapatite (CaHA) is a biodegradable mineral microsphere that mainly works as a biostimulator — it prompts your body to make new collagen (neocollagenesis) for firming and lift. A plain HA filler mostly adds immediate volume. HYALMASS CaHA+ combines both: HA for instant volume and CaHA for gradual collagen.

Conventional CaHA fillers suspend the microspheres in carboxymethylcellulose (CMC), which can cause more initial swelling and isn’t reversible. HYALMASS CaHA+ carries the CaHA in cross-linked HA instead, which is associated with less early swelling and means the HA portion can be dissolved with hyaluronidase if needed.

The hyaluronic-acid portion can be dissolved with hyaluronidase, allowing some adjustment — an advantage over pure CaHA fillers. The calcium-hydroxylapatite microspheres themselves are not enzymatically dissolvable and resorb naturally over time.

The HA gives the early effect and the CaHA-stimulated collagen sustains it; results are commonly reported in the 12–24 month range, varying with the area treated, technique and individual factors.

It is used for facial contouring and volume such as nasolabial folds, marionette lines, cheeks and chin, and also for general skin-quality and bio-revitalisation. The treatment plan is set by the practitioner.

No. It is a ready-to-use pre-filled syringe and does not require reconstitution or hydration before injection.

It is for licensed medical practitioners only, using aseptic technique. CaHA and HA fillers generally have well-characterised safety profiles, but it is contraindicated with known hypersensitivity to the components and over areas of active infection. Regulatory status varies by region — verify local clearance before use.